-
Journal of Receptor, Ligand and Channel Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Pharmacological characterization of oxime agonists of the histamine H4 receptor
Original Research
(2157) Views (1258) Full article downloads
Authors: Fuqu Yu, Ronald L Wolin, Jianmei Wei, et al
Published Date December 2009
Volume 2010:3 Pages 37 - 49
DOI: http://dx.doi.org/10.2147/JRLCR.S6468
Fuqu Yu, Ronald L Wolin, Jianmei Wei, Pragnya J Desai, Patricia M McGovern, Paul J Dunford, Lars Karlsson, Robin L Thurmond
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, CA, USA
Abstract: The histamine H4 receptor (H4R) has generated excitement as a potential target for the development of novel anti-inflammatory therapies. However, many of its physiological functions are still being uncovered and the development of new pharmacological tools is crucial to help facilitate this work. Previously, indole and benzimidazole piperazines have been described as potent and selective H4R antagonists. Using this as a starting point we have identified new indole and benzimidazole oxime piperidines as ligands for the H4R. These compounds have a high affinity for the human H4R with Ki values ranging from 17–53 nM. They also have high to moderate affinity for the H4R from mouse, rat, guinea pig, and monkey, but poor affinity for the dog homologue. In addition to the high affinity for the H4R, these compounds also exhibit excellent selectivity against other histamine receptors as well as many other receptor targets. These oxime ligands act as agonists of the human H4R in transfected reporter systems, although the degree of agonism depends on the system utilized. Agonistic activity was also observed in human eosinophils as evidenced by their ability to induce a shape change in these cells, although the degree of agonism ranges from full agonist to partial agonist depending on the test conditions. In contrast to their activity at the human H4R, all of the oxime compounds act as full agonists at the mouse receptor regardless of the test system including the ability to induce a calcium response in mouse bone marrow-derived mast cells. Finally the most selective compound, JNJ 28610244, was shown to induce scratching in mice indicating that it can also function as an agonist in vivo.
Keywords: H4 receptor, eosinophils, mast cells, pruritus
Readers of this article also read:
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Everolimus-eluting stents: update on current clinical studies
Erratum
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- Discrimination between biological interfaces and crystal-packing contacts
- A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells




